| Literature DB >> 28445736 |
Petko Fiziev1, Kadir C Akdemir2, John P Miller2, Emily Z Keung2, Neha S Samant2, Sneha Sharma2, Christopher A Natale3, Christopher J Terranova2, Mayinuer Maitituoheti2, Samirkumar B Amin4, Emmanuel Martinez-Ledesma2, Mayura Dhamdhere2, Jacob B Axelrad2, Amiksha Shah2, Christine S Cheng5, Harshad Mahadeshwar6, Sahil Seth6, Michelle C Barton7, Alexei Protopopov6, Kenneth Y Tsai8, Michael A Davies9, Benjamin A Garcia3, Ido Amit10, Lynda Chin11, Jason Ernst12, Kunal Rai13.
Abstract
The extent and nature of epigenomic changes associated with melanoma progression is poorly understood. Through systematic epigenomic profiling of 35 epigenetic modifications and transcriptomic analysis, we define chromatin state changes associated with melanomagenesis by using a cell phenotypic model of non-tumorigenic and tumorigenic states. Computation of specific chromatin state transitions showed loss of histone acetylations and H3K4me2/3 on regulatory regions proximal to specific cancer-regulatory genes in important melanoma-driving cell signaling pathways. Importantly, such acetylation changes were also observed between benign nevi and malignant melanoma human tissues. Intriguingly, only a small fraction of chromatin state transitions correlated with expected changes in gene expression patterns. Restoration of acetylation levels on deacetylated loci by histone deacetylase (HDAC) inhibitors selectively blocked excessive proliferation in tumorigenic cells and human melanoma cells, suggesting functional roles of observed chromatin state transitions in driving hyperproliferative phenotype. Through these results, we define functionally relevant chromatin states associated with melanoma progression.Entities:
Keywords: CBP; ChIP-seq; DUSP5; HDAC; chromatin state; epigenome; histone modifications; melanoma
Mesh:
Substances:
Year: 2017 PMID: 28445736 PMCID: PMC5473172 DOI: 10.1016/j.celrep.2017.03.078
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423